172 related articles for article (PubMed ID: 16907658)
1. Hypersensitivity reactions associated with oxaliplatin.
Saif MW
Expert Opin Drug Saf; 2006 Sep; 5(5):687-94. PubMed ID: 16907658
[TBL] [Abstract][Full Text] [Related]
2. Hypersensitivity reactions to oxaliplatin and other antineoplastic agents.
Syrigou E; Syrigos K; Saif MW
Curr Allergy Asthma Rep; 2008 Mar; 8(1):56-62. PubMed ID: 18377776
[TBL] [Abstract][Full Text] [Related]
3. Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction.
Saif M; Roy S; Ledbetter L; Madison J; Syrigos K
World J Gastroenterol; 2007 Oct; 13(39):5277-81. PubMed ID: 17876901
[TBL] [Abstract][Full Text] [Related]
4. Hypersensitivity reactions associated with oxaliplatin and their clinical management.
Toki MI; Saif MW; Syrigos KN
Expert Opin Drug Saf; 2014 Nov; 13(11):1545-54. PubMed ID: 25307143
[TBL] [Abstract][Full Text] [Related]
5. Clinical Features of Oxaliplatin Induced Hypersensitivity Reactions and Therapeutic Approaches.
Bano N; Najam R; Qazi F; Mateen A
Asian Pac J Cancer Prev; 2016; 17(4):1637-41. PubMed ID: 27221832
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
[TBL] [Abstract][Full Text] [Related]
7. Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging the Efficacy of a Desensitization Protocol.
Okayama T; Ishikawa T; Sugatani K; Yoshida N; Kokura S; Matsuda K; Tsukamoto S; Ihara N; Kuriu Y; Nakanishi M; Nakamura T; Kamada K; Katada K; Uchiyama K; Takagi T; Handa O; Konishi H; Yagi N; Naito Y; Otsuji E; Hosoi H; Miki T; Itoh Y
Clin Ther; 2015 Jun; 37(6):1259-69. PubMed ID: 25862137
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity Reactions.
Tampellini M; Benedetto S; Rubatto E; Baratelli C; DI Scipio F; Pirro E; Brizzi MP; Sonetto C; DI Maio M; Berta GN; Scagliotti GV
Anticancer Res; 2016 Oct; 36(10):5163-5170. PubMed ID: 27798876
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity Reactions to oxaliplatin: incidence and management.
Gowda A; Goel R; Berdzik J; Leichman CG; Javle M
Oncology (Williston Park); 2004 Nov; 18(13):1671-5; discussion 1676, 1680, 1683-4. PubMed ID: 15648298
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management.
Hewitt MR; Sun W
Clin Colorectal Cancer; 2006 Jul; 6(2):114-7. PubMed ID: 16945166
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions.
Kuo JC; Hawkins C; Yip D
Intern Med J; 2014 May; 44(5):442-9. PubMed ID: 24393214
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.
Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN
Clin Colorectal Cancer; 2009 Apr; 8(2):106-9. PubMed ID: 19739272
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity to oxaliplatin: clinical features and risk factors.
Parel M; Ranchon F; Nosbaum A; You B; Vantard N; Schwiertz V; Gourc C; Gauthier N; Guedat MG; He S; Kiouris E; Alloux C; Vial T; Trillet-Lenoir V; Freyer G; Berard F; Rioufol C
BMC Pharmacol Toxicol; 2014 Jan; 15():1. PubMed ID: 24417770
[TBL] [Abstract][Full Text] [Related]
14. Clinical Analysis of Hypersensitivity Reactions to Oxaliplatin Among Colorectal Cancer Patients.
Shen Y; Li C; Liu W; Mao W; Qian H; Wang H; Xu Q
Oncol Res; 2018 Jun; 26(5):801-807. PubMed ID: 29295722
[TBL] [Abstract][Full Text] [Related]
15. Skin testing and hypersensitivity reactions to oxaliplatin.
Garufi C; Cristaudo A; Vanni B; Bria E; Aschelter AM; Santucci B; Terzoli E
Ann Oncol; 2003 Mar; 14(3):497-8. PubMed ID: 12598359
[No Abstract] [Full Text] [Related]
16. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
Wong JT; Ling M; Patil S; Banerji A; Long A
J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of reintroducing oxaliplatin to patients with colorectal cancer after mild hypersensitivity reactions.
Park SJ; Lee KY; Park WS; Min SY
Oncology; 2013; 85(6):323-7. PubMed ID: 24247529
[TBL] [Abstract][Full Text] [Related]
18. Hypersensitivity reactions to oxaliplatin: experience in a single institute.
Siu SW; Chan RT; Au GK
Ann Oncol; 2006 Feb; 17(2):259-61. PubMed ID: 16282245
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity reactions to oxaliplatin: what nurses need to know.
Bonosky K; Miller R
Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843
[TBL] [Abstract][Full Text] [Related]
20. A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial.
Yoshida Y; Hirata K; Matsuoka H; Iwamoto S; Kotaka M; Fujita H; Aisu N; Hoshino S; Kosaka T; Maeda K; Kiyomi F; Yamashita Y
Drug Des Devel Ther; 2015; 9():6067-73. PubMed ID: 26648694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
